Dysregulation in the IGF-1 system in type 1 diabetes is associated not only with pure metabolic control but also with the development of severe complications such as end-stage renal disease and diabetes enteropathy [26, 27]. This evidence concerns the gene IGF1 and stage 5 chronic kidney disease.